Literature DB >> 30733230

C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing lncRNA DUSP5P1 and Associates with Patient Outcomes.

Xiaohong Wang1,2, Qiaoyi Liang2, Lianhai Zhang1, Hongyan Gou2, Ziyu Li1, Huarong Chen2, Yujuan Dong2, Jiafu Ji3, Jun Yu4.   

Abstract

PURPOSE: We identified for the first time that C8orf76 (chromosome 8 open reading frame 76) is preferentially amplified in gastric cancer. We elucidated its role and clinical significance in gastric carcinogenesis. EXPERIMENTAL
DESIGN: The clinical impact of C8orf76 was assessed in 592 patients with gastric cancer. The biological function of C8orf76 was studied in vitro, in vivo, and in gastric cancer patient-derived organoid models. C8orf76 downstream effector and pathways were identified by RNA sequencing, chromatin immunoprecipitation sequencing, luciferase reporter, and electrophoretic mobility shift assay.
RESULTS: C8orf76 was upregulated in 69.74% and 65.71% of two independent cohorts of gastric cancers and was positively associated with C8orf76 amplification. Multivariate analysis showed that gastric cancer patients with C8orf76 amplification (cohort I, n = 129; cohort II, n = 107) or overexpression (n = 356) had a significantly shortened survival. C8orf76 significantly promoted gastric cancer cell proliferation, cell-cycle transformation, and migration/invasion, but suppressed cell apoptosis. Silencing C8orf76 expression exerted opposite effects in vitro and significantly inhibited xenograft tumor growth, lung metastasis, and liver metastasis in nude mice. Silencing C8orf76 also significantly suppressed the growth of patient-derived organoids. Mechanically, C8orf76 activated MAPK/ERK signaling cascade. C8orf76 directly bound to the promoter region of lncRNA dual specificity phosphatase 5 pseudogene 1 (DUSP5P1) with a binding motif of AGGCTG and activated DUSP5P1 transcription. DUSP5P1 induced MAPK/ERK signaling and promoted gastric tumorigenesis. Knockdown DUSP5P1 abrogated the effect of C8orf76 in activating MAPK/ERK cascade and the tumor-promoting function.
CONCLUSIONS: C8orf76 directly binds to oncogenic lncRNA DUSP5P1 to induce its expression and activates MAPK signaling. C8orf76 plays a pivotal oncogenic role in gastric carcinogenesis and is an independent prognostic factor for gastric cancer patients. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30733230     DOI: 10.1158/1078-0432.CCR-18-2804

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

2.  Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis.

Authors:  Qingyang Meng; Xiangjun Wang; Tongqing Xue; Qiangfang Zhao; Wei Wang; Kun Zhao
Journal:  Cancer Cell Int       Date:  2020-08-27       Impact factor: 5.722

3.  Construction of a Pearson- and MIC-Based Co-expression Network to Identify Potential Cancer Genes.

Authors:  Na Xu; Dan Cao; Yuan Chen; Hongyan Zhang; Yuting Li; Zheming Yuan
Journal:  Interdiscip Sci       Date:  2021-10-25       Impact factor: 2.233

4.  LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5.

Authors:  Yan Zheng; Tianshui Lei; Guangfu Jin; Haiyang Guo; Nasha Zhang; Jie Chai; Mengyu Xie; Yeyang Xu; Tianpei Wang; Jiandong Liu; Yue Shen; Yemei Song; Bowen Wang; Jinming Yu; Ming Yang
Journal:  EMBO Rep       Date:  2021-09-02       Impact factor: 8.807

Review 5.  MAP Kinases Pathways in Gastric Cancer.

Authors:  Lucia Magnelli; Nicola Schiavone; Fabio Staderini; Alessio Biagioni; Laura Papucci
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

Review 6.  Organoid of ovarian cancer: genomic analysis and drug screening.

Authors:  H-D Liu; B-R Xia; M-Z Jin; G Lou
Journal:  Clin Transl Oncol       Date:  2020-01-14       Impact factor: 3.405

Review 7.  Clinical Implementation of Precision Medicine in Gastric Cancer.

Authors:  Jaewook Jeon; Jae-Ho Cheong
Journal:  J Gastric Cancer       Date:  2019-08-12       Impact factor: 3.720

8.  Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.

Authors:  Shangce Du; Zhi Yang; Xiaofeng Lu; Suhail Yousuf; Min Zhao; Wenxi Li; Ji Miao; Xingzhou Wang; Heng Yu; Xinya Zhu; Hong Chen; Linseng Shi; En Xu; Xuefeng Xia; Wenxian Guan
Journal:  Oncogene       Date:  2021-08-02       Impact factor: 9.867

9.  Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1.

Authors:  Yifan Lian; Changsheng Yan; Yikai Lian; Renzhi Yang; Qiongyun Chen; Dan Ma; Weibin Lian; Jingjing Liu; Chengyan Luo; Jianlin Ren; Hongzhi Xu
Journal:  Cell Death Dis       Date:  2020-07-10       Impact factor: 8.469

10.  FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer.

Authors:  Purong Zhang; Qimin Long; Shiyan Zeng; Min Wen; Qing Lu
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.